CLINICAL-DYNAMIC AND BIOLOGICAL ASPECTS OF POLYMORPHISM AND EFFICACY OF THERAPY OF MOOD DISORDERS

Objective: to study clinical-biological features of affective disorders including their comorbidity with coronary artery disease and personality disorders and efficacy of psychopharmacotherapy in these patients.
Material and Methods. In the first group at a heart station 290 patients with chronic coronary artery disease and affective disorders (209 men and 81 women) were fully examined. The second group included 120 patients (40 men and 80 women) of a psychiatric hospital with affective disorder comorbid with personality disorders. The third group included the study of 29 patients with depressive disorders and a control group (n=21).
Results. Data on significant clinical-dynamic, biological and therapeutic features of affective disorders comorbid with coronary artery disease were obtained. It was revealed that presence of a comorbid personality disorder in the case of affective disorders causes the necessity to use a combined psychopharmacotherapy more frequently, worsens indicators of the efficacy of the psychopharmacotherapy of current episode of depression, and increases negative estimation of their social adaptation by these patients. Dysregulation of the processes of programmed cell death in patients with depressive disorders was found.
Conclusion. Obtained data testified to the high degree of comorbidity of affective disorders with coronary artery disease and personality disorders which worsened the prediction of the course and indicators of the efficacy of psychopharmacotherapy of these disorders. In patients with depressive disorders the specific weight of mononuclears of peripheral blood was increased in the state of apoptosis.

1. Chronobiological theory of affective disorders / under the general editorship of S. N. Mosolov. Moscow: AVANPORT; 2014: 352 (In Russ).

2. De Hert M., Detraux J., Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin. Neurosci. 2018 Mar; 20(1): 31–40.

3. Mavrides N., Nemeroff C. B. Treatment of affective disorders in cardiac disease. Dialogues Clin. Neurosci. 2015 Jun; 17(2): 127–140.

4. Simutkin G. G., Yakovleva A. L., Bokhan N. A. The problem of comorbidity of affective disorders and personality disorders (review of foreign literature). Social’naya i klinicheskaya psihiatriya = Social and clinical psychiatry. 2014; 24(2): 91–97.

5. Friborg O., Martinsen E. W., Martinussen М., Kaiser S., Overgård K. T., Rosenvinge J. H. Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J. Affect. Disord. 2014 Jan; 152–154: 1–11. DOI: 10.1016/j.jad.2013.08.023.

6. Jylhä P., Rosenström T., Mantere O., Suominen K., Melartin T., Vuorilehto M., Holma M., Riihimäki K., Oquendo M. A., Keltikangas-Järvinen L., Isometsä E. T. Personality disorders and suicide attempts in unipolar and bipolar mood disorders. J. Affect. Disord. 2016 Jan 15; 190: 632–639. DOI: 10.1016/j.jad.2015.11.006.

7. Gunderson J. G., Stout R. L., Shea M. T., Grilo C. M., Markowitz J. C.,Morey L. C., Sanislow C., Yen S., Zanarini M. C., Keuroghlian A. S., McGlashan T. H., Skodol A. E. Interactions of borderline personality disorder and mood disorders over 10 years. J. Clin. Psychiatry. 2014 Aug; 75(8): 829–834. DOI: 10.4088/JCP.13m08972.

8. Friborg O., Martinussen M., Kaiser S., Overgård K. T., Rosenvinge J. H. Comorbidity of personality disorders in anxiety disorders: a meta-analysis of 30 years of research. J. Affect. Disord. 2013 Feb 20; 145(2): 143–155. DOI: 10.1016/j.jad.2012.07.004.

9. Wongpakaran N., Wongpakaran T., Boonyanaruthee V., Pinyopornpanish M., Intaprasert S. Comorbid personality disorders among patients with depression. Neuropsychiatr. Dis. Treat. 2015 Apr; 11: 1091–1096. DOI: 10.2147/NDT.S82884.

10. Beatson J. A., Rao S. Depression and borderline personality disorder. Med. J. Aust. 2013 Sep 16; 199 (6): 24–27.

11. Crawford M. J., Price K., Rutter D., Moran P., Tyrer P., Bateman A., Fonagy P., Gibson S., Weaver T. Dedicated community-based services for adults with personality disorder: Delphi study. Br. J. Psychiatry. 2008 Oct; 193(4): 342–343. DOI: 10.1192/bjp.bp.107.043042.

12. Cai S., Huang S., Hao W. New hypothesis and treatment targets of depression: an integrated view of key findings. Neurosci. Bull. 2015 Feb; 31(1): 61–74. DOI: 10.1007/s12264-014-1486-4.

13. Carvalho A. F., Miskowiak K. K., Hyphantis T. N., Kohler C. A., Alves G. S., Bortolato B. G., Sales P. M., Machado-Vieira R., Berk M., McIntyre R. S. Cognitive dysfunction in depression — pathophysiology and novel targets. CNS Neurol. Disord. Drug Targets. 2014; 13(10): 1819–1835.

14. Barman J., Kumar R., Saha G., Tiwari K., Dubey V. K. Mediator molecules, interplay with other cell death processes and therapeutic potentials. Curr. Pharm. Biotechnol. 2018 Aug 20. DOI: 10.2174/1389201019666180821093239.

15. Gladkevich A., Kauffman H. F., Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2004 May; 28(3): 559–576.

16. Melton S. T. Are Cholesterol Levels Linked to Bipolar Disorder? Posted: 05/16/2011.

17. Lymphocytes: secretion, fractionation and characteristics / ed. by J. B. Natvig. Moscow: Medicine; 1980: 280.

18. Miguel-Hidalgo J. J., Whittom A., Villarreal A., Soni M., Meshram A., Pickett J. C., Rajkowska G., Stockmeier C. A. Apoptosis-related proteins and proliferation markers in the orbitofrontal cortex in major depressive disorder. J. Affect. Disord. 2014 Apr; 158: 62–70. DOI: 10.1016/j.jad.2014.02.010.

19. Lucassen P. J., Vollmann-Honsdorf G. K., Gleisberg M., Czéh B., De Kloet E. R., Fuchs E. Chronic psychosocial stress differentially affects apoptosis in hippocampal subregions and cortex of the adult tree shrew. Eur. J. Neurosci. 2001 Jul; 14(1): 161–166.

20. Ivanova S. A., Semke V. Y., Vetlugina T. P., Rakitina N. M., Kudyakova T. A., Simutkin G. G. Signs of apoptosis of immunocompetent cells in patients with depression. Neurosci. Behav. Physiol. 2007 Jun; 37(5): 527–530.

21. Szuster-Ciesielska A., Słotwińska M., Stachura A., Marmurowska-Michałowska H., Dubas-Slemp H., Bojarska-Junak A., Kandefer-Szerszeń M. Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2008 Apr 1; 32(3): 686–694.

22. Kino T. Stress, glucocorticoid hormones, and hippocampal neural progenitor cells: implications to mood disorders. Front Physiol. 2015 Aug; 6: 230. DOI: 10.3389/fphys.2015.00230.